Welcome to LookChem.com Sign In|Join Free

CAS

  • or

3775-05-1

Post Buying Request

3775-05-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3775-05-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 3775-05-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,7,7 and 5 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 3775-05:
(6*3)+(5*7)+(4*7)+(3*5)+(2*0)+(1*5)=101
101 % 10 = 1
So 3775-05-1 is a valid CAS Registry Number.

3775-05-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name methyl 3-formyl-2-hydroxybenzoate

1.2 Other means of identification

Product number -
Other names 3-formyl-2-hydroxybenzoic acid methyl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3775-05-1 SDS

3775-05-1Relevant articles and documents

NOVEL PYRIDOPYRIMIDINONE COMPOUNDS FOR MODULATING THE CATALYTIC ACTIVITY OF HISTONE LYSINE DEMETHYLASES (KDMS)

-

Page/Page column 98-99, (2016/05/19)

The present invention provides a compound of Formula (I) being capable of modulating the activity of histone lysine demethylase (KDM), pharmaceutical compositions thereof, methods to prepare the said compounds, and the use of such compounds as a medicament. The compound of Formula (I) acts as KDM inhibitor with marked potency, thereby having an outstanding potential for a pharmaceutical intervention of cancer and any other diseases related to KDM dysregulation.

Erratum: Design, synthesis and evaluation of aspirin analogues having an additional carboxylate substituent for antithrombotic activity (Bioorganic and Medicinal Chemistry Letters (2009) 19 (4213-4216))

Alagha, Ahmed,Moman, Edelmiro,Adamo, Mauro F.A.,Nolan, Kevin B.,Chubb, Anthony J.

supporting information, p. 398 - 398 (2015/02/18)

-

Salicylic acid derivatives, processes for their preparation, compositions comprising them, their use

-

, (2008/06/13)

Salicylic acid derivatives of the formula I, where the index and the substituents have the following meanings: X is halogen, NO2, cyano, alkyl or alkoxy; m is 0, 1, 2 or 3, it being possible for the substituents X to be different from each othe

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 3775-05-1